Nymox Pharmaceutical Corporation {NASDAQ: NYMX} has confirmed it will issue its report earnings on Tuesday March, 29.
NYMX shares fell 4% on Friday.
Author Archives: admin
Canadian governement proposed bank “bail in” legislation – Does this create a lottery?
The Canadian government is proposing a “bail in” mechanism for Canadian banks very similar to the provisions currently in force in Europe, and used in Cyprus.
This is supposedly to “protect the taxpayer”, but aren’t they the same as people as account holders? Well not quite, and this therefore creates a lottery. Continue reading
Canada’s banking regulator is urging the country’s major banks to review their accounting practices
Canada’s banking regulator is urging the country’s major banks to review their accounting practices to ensure they have sufficient reserves as the commodity-price collapse takes a toll on the economy.
This was reported widely, but specifically in the Wall St.Journal. Continue reading
Nymox director George Robinson adds to his existing holding
Nymox Pharmaceutical {NASDAQ: NYMX} director James Robinson purchased 40,000 shares on Thursday 24th March according to a filing report.
Robinson, purchased at an average price of $2.29. Continue reading
Legendary investment fund manager Stan Druckenmiller moves into gold
Legendary macro investor Stan Druckenmiller has put 30% of his publicly disclosed portfolio into gold.
Druckenmiller has not previously been noted for bullishness on gold, so this latest move has surprised market followers. Continue reading
Scorpio Gold Announces 2016 Production Forecast
Scorpio Gold Corporation {TSX.V: SGN} announces its 2016 guidance and budget for the 70% owned Mineral Ridge project, located in Nevada.
Production will be lower in 2016, then rise again in 2017. Cash costs have risen slightly higher as a result. Continue reading
Inovio’s DNA-based monoclonal antibody and DNA vaccine provide 100% protection against lethal chikungunya virus
Inovio Pharmaceutical {NASDAQ: INO} monoclonal antibody and DNA vaccine provide 100% protection against lethal chikungunya virus challenge in preclinical study.
Ability of unique dMAb and DNA vaccine combination to induce rapid short-term and long-term protection has broad implications for infectious disease prevention and control. Continue reading
Condor negotiate revised terms to acquire the Espinito-Mendoza Concession
Condor Gold Plc {AIM: CNR} has negotiated revised terms and will acquire the Espinito-Mendoza Concession now these have been agreed.
A small $30,000 dollar initial deposit to be followed by $470,000 by the end of June possibly suggests a financing will occur between the two dates. Continue reading
TSX Venture Exchange up in 2016 after rise in the price of gold
The Toronto Venture Exchange has surged up over 10% in 2016, assisted by the 15% increase in the price of gold, and a strong rally in selective gold miners and advanced development projects.
Q1 in any new year is normally positive for the index, but after such a poor year in 2015, such a rise was not expected.
Inovio Pharmaceuticals Acquires Needle-Free Injection Technology to Advance Strategy for Next-Generation Vaccines
Inovio pharmaceuticals {NASDAQ: INO} have acquired Bioject Medical Technologies Inc.’s assets including pioneering needle-free jet injection technology, devices, and intellectual property.
Inovio will pay Bioject $5.5 million in cash and stock. Continue reading
Kootenay Silver partner Northair announces April 14th date for shareholder vote of approval
Northair Silver Corp. {TSX.V: INM} is pleased to announce that it has filed its management information circular and related proxy materials on SEDAR in advance of the Company’s special meeting of shareholders to be held on April 14, 2016 to seek approval of the proposed plan of arrangement with Kootenay Silver Inc.{TSX.V: KTN} Continue reading
Inovio Signs Collaborative Research Agreements With Wistar Institute for DNA-based Immunotherapies and Vaccines
Inovio Pharmaceuticals {NASDAQ: INO} has signed a collaborative agreement with the Wistar Institute for DNA based immunotherapies and vaccines.
Inovio will have the exclusive right to in-license new intellectual property developed in this collaboration. Continue reading
Avalon CEO Don Bubar chairs packed Lithium session at the PDAC
Avalon Advanced Materials {TSX: AVL} CEO Don Bubar chaired a packed out lithium event at the recent PDAC.
Gold and lithium shared the spotlight at the recent event. Continue reading
Scorpio Gold release final drill results from Oromonte satellite
Scorpio Gold Corporation {TSX-V: SGN} reported final results from its 2016 exploration drilling program on the Oromonte satellite deposit at the 70% owned Mineral Ridge project, located in Nevada. Continue reading
Neometals to pay a 2 cents per share unfranked dividend
Neometals {ASX: NMT} has conformed it is to pay shareholders a 2 cents per share unfranked dividend.
The qualification date is 22nd March 2016.
PDAC attendance down again
PDAC 2016 reported a reduced attendance from the previous year,continuing the trend of lower attendances year on year for several years in a row now.
A total of around 22,000 delegates attended in 2016, down from 23,500 reported in 2015. Continue reading
WesternZagros announces that the transition of operatorship of the Garmian Block in the Kurdistan Region of Iraq from WesternZagros to Gazprom Neft
WesternZagros Resources. {TSX.V: WZR} announces that the transition of operatorship of the Garmian Block in the Kurdistan Region of Iraq from WesternZagros to Gazprom Neft.
This is in accordance with the production sharing contract. Continue reading
Inovio Pharmaceuticals Appoints DNA Immunotherapy Pioneer David B. Weiner, to its BOD
Inovio Pharmaceuticals {NASDAQ: INO} have announced the appointment of David Weiner to its Board of Directors.
David is a pioneer in immunotherapy. Continue reading
PDAC 2016 Report – Day 4
PDAC 2016 Report – Day 4
A light attendance on the last day of the conference is normal, and 2016 was no exception.
After four feet aching days of trudging around, the final bell tolled at midday, and the remaining stalwarts breathed a collective sigh of relief and headed towards the exit, and Pearson Airport for the overnight flight home. Continue reading
PDAC 2016 Report – Day 3
PDAC 2016 – Day 3
Following the pattern of previous years there were fewer attendees on the third day of the show.
Talking to exhibitors reaction was mixed about the success of the show. Continue reading